Webinar: Diagnostics Startups
While investments in biotech have reached record highs in recent years, investment in the diagnostics sector from traditional VCs has cooled. This is despite a rapid decline in the cost of sequencing and increased public interest in the potential of precision medicine. In this webinar, Osage University Partners explores the unique challenges facing diagnostics with Garheng Kong, a Managing Partner at HealthQuest Capital, a LabCorp director and active diagnostics investor, and Doug Fisher, CBO of Sera Prognostics and partner at InterWest Partners, also active in diagnostics.